Shanxi Pharma Chairman sells 25.25 mln shrs

The Stock Exchange of Hong Kong has received a Director's and Chief Executive's notice from David Shi, Deputy Chairman of Shanxi Central Pharmaceutical International Limited (0327), reporting a decrease in his interests in Shanxi Central Pharmaceutical International by 25.25 million shares.

Related stock : (NIL)